| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9978611 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 8 Pages |
Abstract
Aberrant expression of hMLH1 and hMSH2 protein is frequently associated with the presence of esophageal squamous cell carcinoma, and expression of hMLH1 protein is a better prognostic predictor than is expression of hMSH2 protein. Promoter methylation is one of the mechanisms responsible for loss of hMLH1 protein in esophageal squamous cell cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ching MD, PhD, Han-Sui MD, Guang-Huan MD, PhD, Hsiou-Lei BS, Yi-Ching PhD, Ho-Jui PhD, Cheng-Ping MD, PhD, Yeung-Leung MD, PhD, Shih-Chun MD,